rosiglitazone has been researched along with interleukin-8 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, ST; Flanigan, A; Jiang, W; Keilbaugh, SA; Lazar, MA; Murthy, S; Rangwala, SM; Su, CG; Wen, X; Wu, GD | 1 |
| Berger, J; Cai, TQ; Li, Y; Shu, H; Wong, B; Woods, JW; Wright, SD; Zhou, G | 1 |
| Blumberg, RS; Kadowaki, T; Kubota, N; Matsuhashi, N; Miki, H; Nagai, R; Nakajima, A; Nakajima, N; Ohnishi, S; Saubermann, LJ; Terauchi, Y; Wada, K | 1 |
| Chan, LY; Lai, KN; Leung, JC; Tang, SC; Tsang, AW | 1 |
| Adamiec, R; Bednarska-Chabowska, D; Dobosz, T; Gacka, M; Sadakierska-Chudy, A; Szymaniec, S | 1 |
| Caito, S; Edirisinghe, I; Kode, A; Phipps, RP; Rahman, I; Rajendrasozhan, S; Yang, SR | 1 |
| Axelsson, J; Ayala, ER; Lindholm, B; Qian, JQ; Stenvinkel, P; Yao, Q | 1 |
| Beguin, Y; de Seny, D; Desoroux, A; Malaise, MG; Relic, B; Zeddou, M | 1 |
| Armani, C; Bardelli, C; Breschi, MC; Brunelleschi, S; Carmazzi, Y; Celi, A; Cordazzo, C; Neri, T; Paggiaro, P; Pegoli, A | 1 |
| Chen, H; Chen, N; Han, L; Lu, Y; Wang, WM; Zhong, F | 1 |
| Koc, M; Kovácová, Z; Kracmerová, J; Langin, D; Malisová, L; Rossmeislová, L; Siklová-Vítková, M; Stich, V; Tencerová, M; Viquerie, N | 1 |
| Fox, JC; Lea, S; Metcalfe, H; Plumb, J; Singh, D; Spicer, D; Woodman, P | 1 |
| Hou, G; Kang, J; Li, ER; Wang, QY; Yin, Y | 1 |
| Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
| Feng, JX; Hua, BJ; Li, HY; Su, YY; Wang, JL; Wang, Q; Yang, S; Zhang, YF | 1 |
| Cantini, G; Cosmi, L; Crescioli, C; Filardi, T; Lenzi, A; Luconi, M; Morano, S; Sottili, M | 1 |
16 other study(ies) available for rosiglitazone and interleukin-8
| Article | Year |
|---|---|
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
Topics: Animals; Caco-2 Cells; Colitis; Cytokines; DNA-Binding Proteins; Epithelium; Gene Expression; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Ligands; Mice; Microbodies; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.
Topics: Cell Nucleus; Cytosol; DNA-Binding Proteins; Fenofibrate; Gene Expression Regulation; Humans; Interleukin-8; Kinetics; Lipopolysaccharides; Matrix Metalloproteinase 9; Monocytes; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 2000 |
Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.
Topics: Animals; Cells, Cultured; Colitis; Epithelial Cells; Gastric Mucosa; Gene Expression; Hypoglycemic Agents; In Vitro Techniques; Intercellular Adhesion Molecule-1; Interleukin-8; Intestinal Mucosa; L-Lactate Dehydrogenase; Liver; Mice; Mice, Inbred BALB C; Mice, Knockout; NF-kappa B; Peroxidase; Pneumonia; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; RNA, Messenger; Rosiglitazone; Stomach; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
Topics: Cell Line; Diabetic Nephropathies; Enzyme Inhibitors; Epithelial Cells; Humans; Immunohistochemistry; Interleukin-8; Kidney; MAP Kinase Signaling System; NF-kappa B; PPAR gamma; RNA, Messenger; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; Thiazolidinediones | 2006 |
Stimulation of the peroxisome proliferator-activated receptor gamma (PPAR gamma) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy.
Topics: Adult; Aged; Atherosclerosis; Cohort Studies; Diabetes Mellitus, Type 2; Down-Regulation; Endothelial Cells; Female; Gene Expression Regulation; Humans; Interleukin-8; Male; Middle Aged; Monocytes; Peripheral Vascular Diseases; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2007 |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages.
Topics: Cell Line; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Hypoglycemic Agents; Immunologic Factors; Interleukin-8; Macrophages; Monocytes; PPAR gamma; Prostaglandin D2; Protein Processing, Post-Translational; Rosiglitazone; Smoke; Smoking; Thiazolidinediones | 2008 |
A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells.
Topics: Angiotensin Receptor Antagonists; Cells, Cultured; Epithelium; Glucose; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Losartan; Peritoneum; PPAR gamma; Rosiglitazone; Signal Transduction; Smad7 Protein; Thiazolidinediones; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2007 |
Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.
Topics: Adipocytes; Adipogenesis; Anti-Inflammatory Agents; Base Sequence; Cell Differentiation; Dexamethasone; DNA Primers; Down-Regulation; Fibroblasts; Genistein; Humans; In Vitro Techniques; Interleukin-6; Interleukin-8; Leptin; Phytoestrogens; PPAR gamma; Prostaglandin D2; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Synovial Membrane; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles.
Topics: Anilides; Bronchi; Calcimycin; Cell Line; Cell-Derived Microparticles; Cells, Cultured; Chemokine CCL2; Humans; Interleukin-8; Ionophores; Monocytes; NF-kappa B; Pneumonia; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2011 |
Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Topics: Anilides; Animals; Blood Urea Nitrogen; Chemokine CCL2; Creatinine; Humans; Hypoglycemic Agents; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; Mice; NF-kappa B; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile.
Topics: Adipocytes; Adipogenesis; Adiponectin; Cells, Cultured; Chemokine CCL2; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-8; Leptin; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones; Weight Loss | 2013 |
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Topics: Adrenal Cortex Hormones; Aged; Animals; Apoptosis; Chemokine CCL5; Dexamethasone; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; Inflammation; Interleukin-8; Ligands; Lipopolysaccharides; Macrophages; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neutrophils; Pioglitazone; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rosiglitazone; Smoking; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
Topics: Animals; Benzhydryl Compounds; Bronchi; Cell Survival; Cells, Cultured; Disease Models, Animal; Down-Regulation; Epithelial Cells; Epoxy Compounds; In Vitro Techniques; Interleukin-8; Leukotriene B4; Male; NF-kappa B; Pneumonia; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Smoking; Thiazolidinediones; Toll-Like Receptor 4; Up-Regulation | 2013 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
PPAR‑γ agonist rosiglitazone protects rat peritoneal mesothelial cells against peritoneal dialysis solution‑induced damage.
Topics: Animals; Aquaporin 1; Dialysis Solutions; Epithelial Cells; Interleukin-6; Interleukin-8; Male; Peritoneal Dialysis; Peritoneum; PPAR gamma; Protective Agents; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Zonula Occludens-1 Protein | 2017 |
Human cell-based anti-inflammatory effects of rosiglitazone.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Humans; Hypoglycemic Agents; Inflammation; Interferon-gamma; Interleukin-8; Myocytes, Cardiac; NF-kappa B; Prognosis; Rosiglitazone; T-Lymphocytes, Helper-Inducer; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2022 |